Sarepta Therapeutics’ report of a second fatality this year in a patient dosed with its Duchenne muscular dystrophy gene therapy raised the ...

For the third time this year, a patient treated with a Sarepta Therapeutics gene therapy has died, a revelation that comes as the company tries to ...